Wenjie He Selected Research

Prosthesis Failure

5/2012

Adenosine A2A receptor activation prevents wear particle-induced osteolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenjie He Research Topics

Disease

4	Wounds and Injuries (Trauma) 02/2024 - 01/2022
3	Neoplasms (Cancer) 01/2024 - 01/2016
2	Bites and Stings (Sting) 02/2024 - 01/2024
2	Infections 01/2024 - 12/2023
2	Ulcer 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2016
2	Inflammation (Inflammations) 05/2012 - 01/2011
2	Bone Resorption 05/2012 - 01/2011
1	Retinoblastoma (Glioblastoma, Retinal) 02/2024
1	Colitis 12/2023
1	Necrosis 12/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023
1	Diabetic Foot 01/2023
1	Fibrosis (Cirrhosis) 01/2022
1	Cerebral Palsy (Spastic Diplegia) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Erythema 01/2022
1	Headache (Headaches) 01/2022
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2022
1	COVID-19 01/2021
1	Anorexia 11/2020
1	Adenocarcinoma 10/2019
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Circulating Neoplastic Cells 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Multiple Myeloma 09/2013
1	Bone Diseases (Bone Disease) 09/2013
1	Osteolysis 05/2012
1	Prosthesis Failure 05/2012
1	Osteoporosis 01/2011
1	Spontaneous Abortion (Miscarriage) 09/2007
1	Placental Insufficiency 09/2007

Drug/Important Bio-Agent (IBA)

2	AntioxidantsIBA 01/2024 - 12/2023
2	EnzymesIBA 12/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2022
2	CytokinesIBA 01/2022 - 01/2016
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2013 - 01/2011
2	Adenosine (Adenocard)FDA LinkGeneric 09/2013 - 01/2011
1	NF-kappa B (NF-kB)IBA 02/2024
1	Antidepressive Agents (Antidepressants)IBA 01/2024
1	asiaticosideIBA 01/2024
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2024
1	MetalsIBA 01/2024
1	InterferonsIBA 01/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2024
1	NanogelsIBA 12/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023
1	Dextrans (Dextran)FDA Link 12/2023
1	SodiumIBA 12/2023
1	Dextran SulfateIBA 12/2023
1	Interleukin-17 (Interleukin 17)IBA 12/2023
1	Substance PIBA 01/2023
1	NeuropeptidesIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	ChemokinesIBA 01/2022
1	InflammasomesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2021
1	VaccinesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Small Interfering RNA (siRNA)IBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	CarcinogensIBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 01/2016
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 05/2012
1	OsteopontinIBA 05/2012
1	Cathepsin KIBA 05/2012
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 05/2012
1	RANK LigandIBA 05/2012
1	ArsenicIBA 09/2007

Therapy/Procedure

1	Surgical Amputation (Amputations) 01/2022
1	Transcranial Direct Current Stimulation 01/2022
1	Massage (Zone Therapy) 11/2020
1	Reoperation 05/2012
1	Aftercare (After-Treatment) 05/2012
1	Therapeutics 01/2011